Allogene Therapeutics, Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|
ANNX
Annexon, Inc. |
$5.19 | $523.15 M | -3.93 | 71 | $0 |
BEAM
Beam Therapeutics Inc. |
$26.58 | $1.91 B | -14.51 | 472 | $377.71 M |
BPMC
Blueprint Medicines Corporation |
$89.36 | $6.47 B | -21.48 | 638 | $249.38 M |
CRBU
Caribou Biosciences, Inc. |
$1.66 | $176.12 M | -1.41 | 158 | $34.48 M |
EDIT
Editas Medicine, Inc. |
$1.22 | $435.86 M | -2.56 | 265 | $78.12 M |
GTHX
G1 Therapeutics, Inc. |
$7.16 | $157.37 M | -5.02 | 100 | $82.51 M |
HRTX
Heron Therapeutics, Inc. |
$1.55 | $542.35 M | -6.55 | 126 | $127.04 M |
ICVX
Icosavax, Inc. |
$15.31 | $769.04 M | -6.96 | 60 | $582,000 |
IPSC
Century Therapeutics, Inc. |
$1.04 | $244.54 M | -1.32 | 152 | $2.24 M |
ITOS
iTeos Therapeutics, Inc. |
$7.33 | $603.25 M | -4.42 | 157 | $12.60 M |
LIFE
aTyr Pharma, Inc. |
$1.90 | $131.12 M | -2.16 | 56 | $353,000 |
MRTX
Mirati Therapeutics, Inc. |
$58.70 | $4.12 B | -4.82 | 587 | $12.44 M |
NTLA
Intellia Therapeutics, Inc. |
$11.98 | $2.19 B | -4.23 | 526 | $36.28 M |
PRME
Prime Medicine, Inc. |
$2.91 | $788.60 M | -3.01 | 234 | $0 |
RLAY
Relay Therapeutics, Inc. |
$4.37 | $1.05 B | -3 | 294 | $25.55 M |
SANA
Sana Biotechnology, Inc. |
$1.61 | $1.55 B | -4.59 | 328 | $0 |
SGMO
Sangamo Therapeutics, Inc. |
$2.56 | $119.17 M | -0.31 | 405 | $176.23 M |
THRX
Theseus Pharmaceuticals, Inc. |
$4.07 | $181.50 M | -3.03 | 38 | $0 |
VECT
VectivBio Holding AG |
$16.87 | $1.06 B | -8.03 | 0 | $27.34 M |
VERV
Verve Therapeutics, Inc. |
$6.01 | $409.24 M | -1.82 | 255 | $11.76 M |